Thomas Guiel
Geschäftsführer bei OXFORD BIODYNAMICS PLC
Vermögen: 66 712 $ am 30.04.2024
Profil
Thomas G.
Guiel is currently the Chief Operating Officer at Oxford BioDynamics Plc.
Previously, he held positions as Principal at Invitrogen Corp., Vice President-Operations at OpGen, Inc., and Chief Operating Officer & Executive Vice President at OncoPlex Diagnostics, Inc. from 2013 to 2018.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OXFORD BIODYNAMICS PLC
0,20% | 03.04.2024 | 623 888 ( 0,20% ) | 66 712 $ | 30.04.2024 |
Aktive Positionen von Thomas Guiel
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Geschäftsführer | - |
Ehemalige bekannte Positionen von Thomas Guiel
| Unternehmen | Position | Ende |
|---|---|---|
OncoPlex Diagnostics, Inc.
 OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Geschäftsführer | 01.01.2018 |
| OPGEN, INC. | Geschäftsführer | - |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OPGEN, INC. | Commercial Services |
| OXFORD BIODYNAMICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD. | Health Services |
